Both social and built environments have a major influence on individuals' health behaviors, health outcomes, and access to resources. Those who live in persistent poverty or underserved areas are likely to experience higher cancer mortality rates, above the risk associated with current poverty. Authors of a study published in JAMA Network Open evaluated persistent poverty over time at the census tract (CT) level, which closely resembles neighborhoods as well as breast tumor characteristics, treatment, and mortality.
For this cohort study, a collection of 18 registries from the Surveillance, Epidemiology, and End Results (SEER) Program was used to identify women aged 18 years or older with stage I to III breast cancer who were diagnosed from January 1, 2010, to December 31, 2018. The dataset also included information about CT-based measures of rural-urban status and persistent poverty. Patients who had missing exposure (or CT-persistent poverty), survival, sociodemographic, or clinical data were excluded.
Sociodemographic variables that were collected included age, race and ethnicity (eg, White, Black, Hispanic, Other), marital status, rural-urban status, and Yost Index (measures socioeconomic status at CT level). Relevant clinical factors included cancer grade, molecular subtype, and SEER summary stages (eg, localized, regional). Molecular subtypes were categorized based on hormone receptor (HR) status (eg, estrogen or progesterone) and the presence of human epidermal growth factor receptor 2 (HER2). Further, receipt of chemotherapy, radiotherapy, breast surgery type (eg, lumpectomy, mastectomy), axillary surgery type, and breast reconstruction were also recorded.
The primary outcomes were all-cause mortality and breast cancer-specific mortality. Follow-up period was from the date of diagnosis to the event date, which was defined as the date of death for patients who died, or either the date of last follow-up or the end of the study for those presumed alive. Secondary outcomes included breast surgery type, axillary surgery type, and receipt of breast reconstruction.